2022 journal article
Transcatheter closure of aneurysmal perimembranous ventricular septal defect with the canine duct occluder in two dogs
Journal of Veterinary Cardiology.
MeSH headings : Dogs; Animals; Cardiac Catheterization / methods; Cardiac Catheterization / veterinary; Heart Septal Defects, Ventricular / diagnostic imaging; Heart Septal Defects, Ventricular / surgery; Heart Septal Defects, Ventricular / veterinary; Septal Occluder Device / veterinary; Heart Aneurysm / diagnostic imaging; Heart Aneurysm / surgery; Heart Aneurysm / veterinary; Echocardiography, Transesophageal; Treatment Outcome; Dog Diseases / diagnostic imaging; Dog Diseases / surgery
TL;DR:
Transcatheter attenuation of perimembranous VSD with membranous ventricular septal aneurysm is clinically feasible using the Canine Duct Occluder and multimodal cardiac imaging allows accurate assessment and planning prior to transcatheter intervention for structural heart disease in dogs.
(via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(OpenAlex)
Source: ORCID
Added: February 23, 2023
Congenital membranous ventricular septal aneurysm has been reported in dogs and can be associated with a perimembranous ventricular septal defect (VSD). The windsock-like ventricular septal aneurysm is formed by tissue of the membranous ventricular septum and portions of the septal leaflet of the tricuspid valve. We report two dogs that underwent transcatheter closure of perimembranous VSD associated with membranous ventricular septal aneurysm using a commercial device marketed for transcatheter closure of patent ductus arteriosus, the canine duct occluder. Partial closure was achieved in the first dog with reduction in left heart dimensions documented on echocardiography both at one day and nine months after procedure. In the second dog, three-dimensional transesophageal echocardiography, cardiac computed tomography, and a three-dimensionally printed whole heart model were used to evaluate feasibility for transcatheter device closure. Complete closure of the VSD was subsequently achieved. Both cases had good short- to medium-term outcomes, no perioperative complications were observed, and both dogs are apparently healthy and receiving no cardiac medications at 34 months and 17 months after procedure. Transcatheter attenuation of perimembranous VSD with membranous ventricular septal aneurysm is clinically feasible using the canine duct occluder, and multimodal cardiac imaging allows accurate assessment and planning prior to transcatheter intervention for structural heart disease in dogs.